HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: California Seeks Federal Animal-Test Ban; PCPC Unveils GMPs Aid; More

This article was originally published in The Rose Sheet

Executive Summary

A joint resolution approved by California’s State Senate calls for a federal ban on cosmetic animal testing; The Personal Care Products Council introduces a new tool companies can use to verify Good Manufacturing Compliance conformance. More news in brief.

You may also be interested in...

Supplement Industry Offers Cautionary Tale For Mandatory Cosmetic GMPs

Roughly six years after publication of FDA’s final rule establishing mandatory Good Manufacturing Practices in the dietary supplement sector, the industry’s noncompliance rate was still at nearly 70% in fiscal 2013, according to FDA data. How GMP requirements are laid out in forthcoming federal legislation to update FDA’s cosmetics oversight program could dictate the potential challenge before industry.

In Brief

The Cruelty Free Cosmetics Resolution passes the California Assembly, aimed at driving congressional support for a federal ban on animal-tested cosmetics and cosmetic ingredients. In other news, Avon and Elizabeth Arden announce cost-cutting initiatives.

Hair Care Springboards Off Skin-Care Trends, Nail Color Slips In 2013

Anti-aging hair care and multifunctional alphabet creams for hair grew in 2013 where skin care left off, according to Kline & Company research. Meanwhile nail-care sales have plateaued after several years of double-digit gains, the market-intelligence firm says.

Related Content

Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts